Regulation of in Vitro Vascular Calcification by BMP4, VEGF and Wnt3a
Overview
Affiliations
Vascular calcification is a common clinical complication of cardiovascular disease, diabetes and end-stage renal failure, associated with significant morbidity and mortality. In this study we demonstrate that factors secreted by the hypertrophic chondrocytes induce matrix mineralization and osteoblastic transformation in cultured mouse vascular smooth muscle cells (VSMCs). In addition, these factors render VSMCs responsive to BMP4 and Wnt3a ligands. Neither BMP-4 nor Wnt3a could induce mineralization in short-term (up to 8 days) cultures of primary mouse VSMCs. However, both ligands act synergistically with the chondrocyte-conditioned medium causing a further increase in VSMC calcification. Finally, we show that commitment of VSMCs towards the BMP-regulated mineralization can be induced by the chondrocyte-secreted bone anabolic factor VEGF. In addition, expression profiling suggests a novel role in vascular calcification for the matrix proteins previously known to regulate bone formation and mineralization (including MMP3, fibulin, 11betahydroxysteroid dehydrogenase 1 and retinoic acid receptor responder 2). The results of this study may contribute to further understanding of the cellular mechanisms responsible for vascular calcification and provide important information for the treatment of this pathology.
Li X, Zhao Y, Jiang G Int Urol Nephrol. 2024; 57(2):613-623.
PMID: 39312016 DOI: 10.1007/s11255-024-04213-3.
Wang S, Wang X, Chen J, Wang M, Zhang C Aging (Albany NY). 2024; 16(11):9369-9385.
PMID: 38809515 PMC: 11210242. DOI: 10.18632/aging.205870.
Significance of the Wnt signaling pathway in coronary artery atherosclerosis.
Khan K, Yu B, Tardif J, Rheaume E, Al-Kindi H, Filimon S Front Cardiovasc Med. 2024; 11:1360380.
PMID: 38586172 PMC: 10995361. DOI: 10.3389/fcvm.2024.1360380.
Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights.
Zaslow S, Oliveira-Paula G, Chen W Int J Mol Sci. 2024; 25(2).
PMID: 38256228 PMC: 10816532. DOI: 10.3390/ijms25021155.
Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.
Anagnostis P, Florentin M, Livadas S, Lambrinoudaki I, Goulis D Int J Mol Sci. 2022; 23(3).
PMID: 35163560 PMC: 8835770. DOI: 10.3390/ijms23031639.